Searched for
ODOMZO
Sun Pharma shares in focus ahead of Q2 results todaySun Pharma Share Price: Sun Pharma is set to announce its Q2 FY25 results, with revenue growth expected to be driven by domestic business a...28 Oct, 2024, 08.18 AM IST- Sun Pharma, Philogen join hands to commercialise skin cancer drug in Europe, Australia, New ZealandSun Pharmaceutical Industries on Tuesday said it has entered into a licensing pact with Philogen SpA to commercialise under-development ski...30 May, 2023, 02.38 PM IST
- Sun Pharma Q3 Preview: Sales likely to rise but profit may fall YoYAccording to an ETNow poll, the drugmaker’s consolidated revenue for the quarter ended December is seen rising 12.5% on-year to Rs 11,100 c...30 Jan, 2023, 10.16 PM IST
- Buy Sun Pharmaceutical Industries, target price Rs 1130: JM FinancialSun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 213972.69 Crore) opera...24 Aug, 2022, 10.21 AM IST
- Does Sun Pharma's specialty portfolio hold key to its performance?According to the FY 2022 annual report of Sun Pharma, it is ranked number 1 in terms of prescriptions with an 8.34% market share in India. ...14 Aug, 2022, 04.48 PM IST
- Buy Sun Pharmaceutical Industries, target Rs 520: CLSASun Pharma is a largecap company, operating in pharmaceuticals and health care sector.29 May, 2019, 05.12 PM IST
- Sun Pharma rises with R&D and bets on specialty drugsSun Pharma- India's largest drug maker - is vying for its share in the US$9 billion market through a drug, Ilumya, that treats moderate-to-...05 Jun, 2018, 12.55 PM IST
- Beyond Sun's pain is a promise of specialty segment: AnalystsSome analysts suggested that investors willing to overlook the subdued outlook.15 Aug, 2017, 08.48 AM IST
- Sun Pharma hits 44-month low, down 24% in 7 sessions; what experts sayThe stock fell 12.84 per cent to hit a 44-month low of Rs 495.55 amid weak fourth quarter results.29 May, 2017, 10.17 AM IST
- Lupin, Cipla, other top drugmakers in fray for Novartis’ brandsThe Novartis portfolio includes top-selling brand TOBI Podhaler, a drug prescribed for symptomatic relief to patients suffering from cystic...31 Mar, 2017, 01.06 AM IST
- Sun Pharma Q3 net profit slips 4.7% YoY to Rs 1,471.82 croreSales for the quarter came in at Rs 7,683.24 crore, compared with Rs 7,087.07 crore in the same quarter last year.15 Feb, 2017, 12.44 AM IST
- How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the USWhile the market opportunities to sell brands appear optimistic, that road is less treaded by Indian companies and obvious challenges can l...07 Jan, 2017, 12.43 AM IST
- Buy Sun Pharma, with a target of Rs 750: Bank of America Merrill LynchBofA-ML maintains buy rating on Sun Pharma but slashed its 12-month target price to Rs 750 from Rs 790 earlier.29 Dec, 2016, 09.11 AM IST
- HSBC says Odomzo deal to strengthen Sun Pharma's specialty business focusThe brokerage has maintained a ‘buy’ rating on the stock with a target price of Rs 797. The target price implies an upside of 27.8% from cu...23 Dec, 2016, 09.40 PM IST
- Sun Pharma to acquire oncology product from Novartis for $175 mnThe agreement has been signed between subsidiaries of both the companies and will close following anti-trust clearance and further closing ...22 Dec, 2016, 11.22 AM IST
- Sun Pharma rallies on acquisition plans to buy Odomzo drug from NovartisAt 09:45 am, shares of Sun Pharma were trading 1.3 per cent higher at Rs 622. They hit a low of Rs 614 and a high of Rs 624 in the first 30...22 Dec, 2016, 10.57 AM IST
- Sun Pharma to buy Novartis' cancer drug OdomzoSun Pharmaceutical today said it has acquired branded oncology product Odomzo from Novartis for an upfront payment of $ 175 million.22 Dec, 2016, 08.50 AM IST
Load More
